These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 28396438)

  • 41. Use of human immunoglobulins as an anti-infective treatment: the experience so far and their possible re-emerging role.
    Bozzo J; Jorquera JI
    Expert Rev Anti Infect Ther; 2017 Jun; 15(6):585-604. PubMed ID: 28480779
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Threat and Response to Infectious Diseases (Revised).
    Brower JL
    Microb Ecol; 2018 Jul; 76(1):19-36. PubMed ID: 27480226
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Emerging diseases and implications for Millennium Development Goals in Africa by 2015 - an overview.
    Aluwong T; Bello M
    Vet Ital; 2010; 46(2):137-45. PubMed ID: 20560123
    [TBL] [Abstract][Full Text] [Related]  

  • 44. United States of America Department of Health and Human Services support for advancing influenza vaccine manufacturing in the developing world.
    Perdue ML; Bright RA
    Vaccine; 2011 Jul; 29 Suppl 1():A48-50. PubMed ID: 21684430
    [TBL] [Abstract][Full Text] [Related]  

  • 45. From plague to MERS: coordinating Australia's response to emerging infectious diseases.
    Firman J; Williams SA; Baggoley C
    Public Health Res Pract; 2016 Dec; 26(5):. PubMed ID: 27997933
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Commentary: Emerging and other communicable diseases.
    Heymann D; Dzenowagis J
    Bull World Health Organ; 1998; 76(6):545-7. PubMed ID: 10191549
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Developing Countries Vaccine Manufacturers Network: doing good by making high-quality vaccines affordable for all.
    Pagliusi S; Leite LC; Datla M; Makhoana M; Gao Y; Suhardono M; Jadhav S; Harshavardhan GV; Homma A
    Vaccine; 2013 Apr; 31 Suppl 2():B176-83. PubMed ID: 23598479
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vaccines for emerging pathogens: from research to the clinic. Part two.
    Williamson ED
    Clin Exp Immunol; 2019 Nov; 198(2):141-142. PubMed ID: 31625155
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Resurgence of Vaccine-Preventable Diseases in the United States: Anesthetic and Critical Care Implications.
    Porteous GH; Hanson NA; Sueda LA; Hoaglan CD; Dahl AB; Ohlson BB; Schmidt BE; Wang CC; Fagley RE
    Anesth Analg; 2016 May; 122(5):1450-73. PubMed ID: 27088999
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Using local knowledge in emerging infectious disease research.
    Gaddy HG
    Soc Sci Med; 2020 Aug; 258():113107. PubMed ID: 32563166
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Zika--an emerging infectious disease. The risk assessment from Polish perspective.
    Gańczak M
    Przegl Epidemiol; 2016; 70(1):1-6, 93-7. PubMed ID: 27344465
    [TBL] [Abstract][Full Text] [Related]  

  • 52. UN Sec-Gen on World Health Day.
    Ghana Off News Bull; 1997 Apr 1-30; 2(7):3. PubMed ID: 12321711
    [TBL] [Abstract][Full Text] [Related]  

  • 53. When an emerging disease becomes endemic.
    Medley GF; Vassall A
    Science; 2017 Jul; 357(6347):156-158. PubMed ID: 28706039
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Climate changes and emerging diseases. What new infectious diseases and health problem can be expected?].
    Stark K; Niedrig M; Biederbick W; Merkert H; Hacker J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Jul; 52(7):699-714. PubMed ID: 19536444
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of biosensors in the detection of emerging infectious diseases.
    Pejcic B; De Marco R; Parkinson G
    Analyst; 2006 Oct; 131(10):1079-90. PubMed ID: 17003853
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Beyond cost-effectiveness: Using systems analysis for infectious disease preparedness.
    Phelps C; Madhavan G; Rappuoli R; Colwell R; Fineberg H
    Vaccine; 2017 Jan; 35 Suppl 1():A46-A49. PubMed ID: 28017432
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Global Health Security Demands a Strong International Health Regulations Treaty and Leadership From a Highly Resourced World Health Organization.
    Burkle FM
    Disaster Med Public Health Prep; 2015 Oct; 9(5):568-80. PubMed ID: 25690046
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vaccine Platform Technologies: A Potent Tool for Emerging Infectious Disease Vaccine Development.
    Adalja AA; Watson M; Cicero A; Inglesby T
    Health Secur; 2020; 18(1):59-60. PubMed ID: 32078422
    [No Abstract]   [Full Text] [Related]  

  • 59. Technology transfer in human vaccinology: a retrospective review on public sector contributions in a privatizing science field.
    Hendriks J
    Vaccine; 2012 Sep; 30(44):6230-40. PubMed ID: 22902679
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Emerging and re-emerging infections diseases: risk and response in Algeria].
    Mesbah S
    Med Trop (Mars); 2009 Feb; 69(1):27-32. PubMed ID: 19499728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.